About
Editas Medicine Inc (NASDAQ:EDIT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 27 2026
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
Mar 9 2026
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Nov 20 2025
Cassidy Bio Launches with the Goal to Develop Safer, More Scalable Gene Editing Therapies
Nov 10 2025
Editas Medicine Announces Third Quarter 2025 Results and Business Updates
Nov 3 2025
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
Recent Videos

🔥 지금 폭등 중인 Editas Medicine, Inc., FormFactor, Inc. | 2026.04.13 미국 장중 실시간
Apr 13, 2026

EDIT STOCK : POTENTIAL RECOVERY | EDITAS MEDICINE STOCK
Apr 12, 2026

Editas Medicine: 200% Kurschance und das Risiko des Totalverlusts – Die brutale Wahrheit über CRISPR
Mar 08, 2026

Editas Medicine Inc. Mystery: Why pivot? How to trade and profit #EDIT
Feb 19, 2026
Financials
Revenue
$40.52 M
Market Cap
$261.32 M
EPS
-1.80
Google Übersetzer